Peer-reviewedLicence not statedCellular and Molecular Immunology
CRISPRa screen unveils noncanonical NF-κB to boost the antitumor activity of TCR-based CAR-T cells
- 1School of Basic Medical Sciences, Tsinghua Medicine, Tsinghua University, Beijing, China
- 2Tsinghua University-Peking University Center for Life Sciences, Beijing, China
- 3Beijing Changping Laboratory, Beijing, China
Related
- An in vivo CRISPR screen unveils promising target genes to improve CAR-T cell efficacy in a solid tumor model
- Antitumor Activity of a Bupleurum chinense-Derived Vesicle-like Particle Preparation in MOC1 Oral Squamous Cell Carcinoma Models
- Lipid-based mRNA chimeric antigen receptor T cells for enhanced in vitro antitumor activity
- 318 CAR-T and CAR-NK cell combination therapy targeting DLL3 or CD70 surface antigens promotes synergistic antitumor activity in small cell lung cancer
- 531 Phase I study to assess the safety, immunogenicity, and preliminary antitumor activity of the EBV mRNA vaccine (WGc-043 injection) in patients with R/R lymphoma
BibTeX
@article{yu2026crispra,
title = {{CRISPRa screen unveils noncanonical NF-κB to boost the antitumor activity of TCR-based CAR-T cells}},
author = {Hanyang Yu and Yingxin Wu and Yue Liu and Ruxue Wei and Zhixiao Zhou and Li Yu and Xin Lin and Jiasheng Wang},
journal = {Cellular and Molecular Immunology},
year = {2026},
month = oct,
doi = {10.1038/s41423-026-01471-2},
url = {https://doi.org/10.1038/s41423-026-01471-2},
}
RIS
TY - JOUR
TI - CRISPRa screen unveils noncanonical NF-κB to boost the antitumor activity of TCR-based CAR-T cells
AU - Hanyang Yu
AU - Yingxin Wu
AU - Yue Liu
AU - Ruxue Wei
AU - Zhixiao Zhou
AU - Li Yu
AU - Xin Lin
AU - Jiasheng Wang
PY - 2026
DA - 2026/10/13
JO - Cellular and Molecular Immunology
DO - 10.1038/s41423-026-01471-2
UR - https://doi.org/10.1038/s41423-026-01471-2
SN - 1672-7681
SN - 2042-0226
ER -